ACADIA Pharmaceuticals, Inc. (ACAD)
23.56
+0.10
(+0.43%)
USD |
NASDAQ |
Feb 06, 16:00
23.54
-0.02
(-0.08%)
After-Hours: 20:00
ACADIA Pharmaceuticals SG&A Expense (TTM) : 523.36M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.365M |
| Dynavax Technologies Corp. | 179.71M |
| Axsome Therapeutics, Inc. | 514.57M |
| Rhythm Pharmaceuticals, Inc. | 175.59M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |